These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 28506928

  • 1. Distinct phosphodiesterase 5A-containing compartments allow selective regulation of cGMP-dependent signalling in human arterial smooth muscle cells.
    Wilson LS, Guo M, Umana MB, Maurice DH.
    Cell Signal; 2017 Aug; 36():204-211. PubMed ID: 28506928
    [Abstract] [Full Text] [Related]

  • 2. Angiotensin II increases phosphodiesterase 5A expression in vascular smooth muscle cells: a mechanism by which angiotensin II antagonizes cGMP signaling.
    Kim D, Aizawa T, Wei H, Pi X, Rybalkin SD, Berk BC, Yan C.
    J Mol Cell Cardiol; 2005 Jan; 38(1):175-84. PubMed ID: 15623434
    [Abstract] [Full Text] [Related]

  • 3. Feedback control through cGMP-dependent protein kinase contributes to differential regulation and compartmentation of cGMP in rat cardiac myocytes.
    Castro LR, Schittl J, Fischmeister R.
    Circ Res; 2010 Nov 12; 107(10):1232-40. PubMed ID: 20847310
    [Abstract] [Full Text] [Related]

  • 4. Compartmentation and compartment-specific regulation of PDE5 by protein kinase G allows selective cGMP-mediated regulation of platelet functions.
    Wilson LS, Elbatarny HS, Crawley SW, Bennett BM, Maurice DH.
    Proc Natl Acad Sci U S A; 2008 Sep 09; 105(36):13650-5. PubMed ID: 18757735
    [Abstract] [Full Text] [Related]

  • 5. Activation of phosphodiesterase 5 and inhibition of guanylate cyclase by cGMP-dependent protein kinase in smooth muscle.
    Murthy KS.
    Biochem J; 2001 Nov 15; 360(Pt 1):199-208. PubMed ID: 11696008
    [Abstract] [Full Text] [Related]

  • 6. Cyclic nucleotide signalling compartmentation by PDEs in cultured vascular smooth muscle cells.
    Zhang L, Bouadjel K, Manoury B, Vandecasteele G, Fischmeister R, Leblais V.
    Br J Pharmacol; 2019 Jun 15; 176(11):1780-1792. PubMed ID: 30825186
    [Abstract] [Full Text] [Related]

  • 7. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation.
    Lee DI, Vahebi S, Tocchetti CG, Barouch LA, Solaro RJ, Takimoto E, Kass DA.
    Basic Res Cardiol; 2010 May 15; 105(3):337-47. PubMed ID: 20107996
    [Abstract] [Full Text] [Related]

  • 8. PKA-dependent activation of PDE3A and PDE4 and inhibition of adenylyl cyclase V/VI in smooth muscle.
    Murthy KS, Zhou H, Makhlouf GM.
    Am J Physiol Cell Physiol; 2002 Mar 15; 282(3):C508-17. PubMed ID: 11832336
    [Abstract] [Full Text] [Related]

  • 9. Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress.
    Russo I, Del Mese P, Doronzo G, Mattiello L, Viretto M, Bosia A, Anfossi G, Trovati M.
    Endocrinology; 2008 Apr 15; 149(4):1480-9. PubMed ID: 18079207
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of PDE5A1 guanosine cyclic monophosphate (cGMP) hydrolysing activity by sildenafil analogues that inhibit cellular cGMP efflux.
    Subbotina A, Ravna AW, Lysaa RA, Abagyan R, Bugno R, Sager G.
    J Pharm Pharmacol; 2017 Jun 15; 69(6):675-683. PubMed ID: 28211580
    [Abstract] [Full Text] [Related]

  • 11. cGMP catabolism by phosphodiesterase 5A regulates cardiac adrenergic stimulation by NOS3-dependent mechanism.
    Takimoto E, Champion HC, Belardi D, Moslehi J, Mongillo M, Mergia E, Montrose DC, Isoda T, Aufiero K, Zaccolo M, Dostmann WR, Smith CJ, Kass DA.
    Circ Res; 2005 Jan 07; 96(1):100-9. PubMed ID: 15576651
    [Abstract] [Full Text] [Related]

  • 12. Antiproliferative effect of sildenafil on human pulmonary artery smooth muscle cells.
    Tantini B, Manes A, Fiumana E, Pignatti C, Guarnieri C, Zannoli R, Branzi A, Galié N.
    Basic Res Cardiol; 2005 Mar 07; 100(2):131-8. PubMed ID: 15739122
    [Abstract] [Full Text] [Related]

  • 13. Thrombospondin-1 inhibition of vascular smooth muscle cell responses occurs via modulation of both cAMP and cGMP.
    Yao M, Roberts DD, Isenberg JS.
    Pharmacol Res; 2011 Jan 07; 63(1):13-22. PubMed ID: 20971192
    [Abstract] [Full Text] [Related]

  • 14. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F, MacLean MR, Pyne NJ.
    Br J Pharmacol; 2002 Dec 07; 137(8):1187-94. PubMed ID: 12466227
    [Abstract] [Full Text] [Related]

  • 15. Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5.
    Takimoto E, Belardi D, Tocchetti CG, Vahebi S, Cormaci G, Ketner EA, Moens AL, Champion HC, Kass DA.
    Circulation; 2007 Apr 24; 115(16):2159-67. PubMed ID: 17420342
    [Abstract] [Full Text] [Related]

  • 16. Sildenafil inhibits hypoxia-induced transient receptor potential canonical protein expression in pulmonary arterial smooth muscle via cGMP-PKG-PPARγ axis.
    Wang J, Yang K, Xu L, Zhang Y, Lai N, Jiang H, Zhang Y, Zhong N, Ran P, Lu W.
    Am J Respir Cell Mol Biol; 2013 Aug 24; 49(2):231-40. PubMed ID: 23526219
    [Abstract] [Full Text] [Related]

  • 17. Antimitogenic actions of organic nitrates are potentiated by sildenafil and mediated via activation of protein kinase A.
    Osinski MT, Rauch BH, Schrör K.
    Mol Pharmacol; 2001 May 24; 59(5):1044-50. PubMed ID: 11306686
    [Abstract] [Full Text] [Related]

  • 18. Mathematical Modelling of Nitric Oxide/Cyclic GMP/Cyclic AMP Signalling in Platelets.
    Kleppe R, Jonassen I, Døskeland SO, Selheim F.
    Int J Mol Sci; 2018 Feb 19; 19(2):. PubMed ID: 29462984
    [Abstract] [Full Text] [Related]

  • 19. Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.
    Lee DI, Zhu G, Sasaki T, Cho GS, Hamdani N, Holewinski R, Jo SH, Danner T, Zhang M, Rainer PP, Bedja D, Kirk JA, Ranek MJ, Dostmann WR, Kwon C, Margulies KB, Van Eyk JE, Paulus WJ, Takimoto E, Kass DA.
    Nature; 2015 Mar 26; 519(7544):472-6. PubMed ID: 25799991
    [Abstract] [Full Text] [Related]

  • 20. Phosphodiesterase-5A and neutral endopeptidase activities in human adipocytes do not control atrial natriuretic peptide-mediated lipolysis.
    Moro C, Klimcakova E, Lafontan M, Berlan M, Galitzky J.
    Br J Pharmacol; 2007 Dec 26; 152(7):1102-10. PubMed ID: 17906676
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.